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Abstract 
The aim of this review was to summarize data from studies making inquiries on levels of 
the cytokines in pathogenesis of peri-implant diseases. Here we reviewed the recent 
developments on IL-1β, IL-10, IL-17, IL-21, and IL-33. We highlighted recent advances 
during the last few years in this area and discussed their roles in immune regulation in 
patients with peri-implant disease.Our results revealed that identifying the levels of these 
cytokines (IL-1β, IL-10, IL-17, IL-21, and IL-33) may help to predict the diagnosis of peri-
implant diseases. From a safety perspective, this study emphasized the need to consider the 
impact of these interleukin on peri-implant diseases. 
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Introduction 
Dental implantation is a surgical process of alloplastic material insertion into the 
hard and soft tissues of maxillary and mandibular jaws (Petkovic-Curcin et al., 
2011). The immune reaction of organism against any artificial material into the 
body is going to protect the organism against pathogens and injuries, and these 
reactions will lead to complete recovery of the tissues and accepting implants or 
break the implant functionality and cause implant failure, so that, in worst 
conditions the implant should be removed (Petkovic-Curcin et al., 2011; 
Kondyurina & Kondyurin, 2020). Peri-implant lesions have shown to contain a 
wide range of inflammatory cell infiltrate, with greater proportions of plasma cells, 
neutrophils and macrophages (Schincaglia et al., 2016). 
Cytokines are small messenger proteins which are mostly secreted by immune cells 
and act as key modulators of immune response by playing a strategic role in 
differentiation, maturation, and activation of various cells types. (Lipiäinen et al., 
2015; Su et al., 2012) Depending on specific local environments, cytokines exhibit 
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either pro-inflammatory effects or anti-inflammatory effects or both (Su et al., 
2012). 
Pro-inflammatory cytokines are immune-regulatory cytokines that promote 
inflammation (Proinflammatory cytokines, 2020).  They are mainly produced by 
activated macrophages and involved in up-regulation of inflammatory process. 
Major pro-inflammatory cytokines include IL-1β, IL-6, and TNF-α (Proinflam-
matory cytokines list, 2020). The anti-inflammatory cytokines are a sequence of 
immune-regulatory molecules that control the Pro-inflammatory response. The 
typical anti-inflammatory cytokines are interleukin (IL)-1 receptor antagonist, IL-4, 
IL-10, IL-11, and IL-13 (Anti-inflammatory cytokines, 2020).  In order to maintain 
health, there should be a balance between pro-inflammatory and anti-inflammatory 
cytokines (Inflammatory cytokine, 2020). Imbalances between these two usually 
obstruct the resolution of inflammation and, instead, lead to tissue destruction 
(Duarte et al., 2016). Inflammatory cytokines can perform as a predictive and 
preventive biological tool as well (Farhad et al., 2019). 
The expression of cytokines is affected by genetic, epigenetic, microbiota 
heterogeneity and environmental factors (Teixeira et al., 2016). Peri-implant 
mucositis and peri- implantitis are two main inflammatory processes affecting 
tissues around the functional dental implant and due to inflammatory disorders, the 
process may cause implant loss. Nevertheless, evaluating the inflammatory 
cytokine levels could be a tool for early diagnose, prevention and therapy of peri-
implant disease (Severino et al., 2016). 
In this sense, saliva is an abundant biological fluid and it’s used as a diagnostic tool 
for a variety and range of diseases. More than 3000 proteins and peptides have 
been characterized by recent proteomic approaches in human saliva involved in 
different biological functions in the oral cavity (Bhattarai et al., 2018; Ventura et 
al., 2018). Thus, salivary cytokines could be important to analyze the changes in 
peri-implant diseases (Fonseca et al., 2012).  Moreover, saliva samples are easy to 
be collected in a noninvasive manner and at low-price, but in few articles, authors 
examined salivary biomarkers to investigate the presence and progression of the 
peri-implant disease (Teixeira et al., 2016). 
The present study was designed to determine the importance of IL-1β, IL-10, IL-
17, IL-21, IL-33 as biochemical markers for early diagnosis and early prevention of 
peri-implant diseases. 
Interleukin 1 beta (IL-1β) - IL-1β is a pro-inflammatory cytokine present in 
healthy peri-implant tissues in certain concentration. The progression of gingival 
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inflammation is due to the consequence of IL-1β and IL-6 activities, which cause a 
significant tissue damage by osteoclasts activation (Petkovic-Curcin et al., 2011).  
 
Interleukin 10, 17 and 21 (IL-10, IL-17 and IL-21) - IL‐10 and IL‐17 are among 
the new cytokines that have not yet been extensively investigated in prior 
researches (Farhad et al., 2019). IL‐10 is a human cytokine with potent anti-
inflammatory properties. Thereby, IL‐10 prevents host damaging by limiting 
immune response to pathogens.  IL‐17 is a pro-inflammatory cytokine that plays 
both protective and tissue destruction role in immune system. The main role of IL-
17 against infection is to influence on neutrophils and activate macrophages in the 
infectious origin (Farhad et al., 2019).  The occurrence of peri-implant disease is 
the result of a dysregulated host immune response to periodontal bacteria.  A 
number of existing studies have recently focused on presence and function of IL-17 
in these diseases (Farhad et al., 2019; Lira-Junior et al., 2019).  According to the 
result of a study conducted in 2014, concentrations of IL-17 reduced as a 
consequence of the progression of gingivitis to periodontitis means that in the 
presence of higher depth of dental pocket the level of IL-17 was decreased 
(Johnson et al., 2004).  In another comparative study between mucositis and peri-
implantitis sites reported in 2016, a significant increase has been found in IL-21 
levels in mucositis than peri-implantitis according to author’s judgment that was 
the first study to investigate the expression of IL-21 in peri-implant disease 
(Teixeira et al., 2016).  
Interleukin 33 (IL-33) - The IL-33 is a member of the IL-1 family and plays a 
central role in immune responses where has recently demonstrated that the 
Production of IL-33 by induction of RANKL is Associated with periodontal 
disease. Therefore, by increasing the levels of IL-33 the tissue destruction may 
increase in mucositis and peri-implantitis (Severino et al., 2016). 
Currently, the frequent diagnostic tools for peri-implant disease are radiographic 
parameters and clinical signs including probing depth, bleeding on probing, 
suppuration, degree of implant mobility and bone loss (Duarte et al., 2016). 
Though, it is not easy to perform all of these diagnostic methods or might not be 
sufficient enough to differentiate the peri-implant disease onset, activity and 
progression; That is why, there is a need of an investigative effort to identify the 
levels of different cytokines which may help to predict more accurate diagnosis, 
activity and progression of peri-implant disease. Particularly few studies have been 
carried out and explored the role of interleukins in the pathogenesis of peri-implant 
diseases (Farhad et al., 2019). 
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Conclusion 
The available evidence suggests that levels of certain interleukins (IL-1β, IL-10, 
IL-17, IL-21, and IL-33) may aid in the diagnosis and early prevention of peri-
implant diseases when used in combination with other biomarkers and approaches. 
Consequently, further research is needed to obtain determinative results in this 
regard. 
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